Cargando…

Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome

Background and Aims: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder. However, the underlying mechanism of IBS is not fully understood. The aim of this study was to investigate potential mechanism and novel biomarkers of IBS through evaluation of the metabolomic and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Shengtao, Liu, Si, Li, Hengcun, Zhang, Zheng, Zhang, Qian, Chen, Lei, Zhao, Yu, Chen, Yang, Gu, Junchao, Min, Li, Zhang, Shutian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813219/ https://www.ncbi.nlm.nih.gov/pubmed/31681624 http://dx.doi.org/10.3389/fcimb.2019.00346

Ejemplares similares

Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome
por: Liu, Si, et al.
Publicado: (2019)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
por: Xiao, Lin, et al.
Publicado: (2021)

Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
por: Jia, Xiaokang, et al.
Publicado: (2021)

The Gut Microbiota in Inflammatory Bowel Disease
por: Qiu, Peng, et al.
Publicado: (2022)

Multiomics Study of Gut Bacteria and Host Metabolism in Irritable Bowel Syndrome and Depression Patients
por: Xu, Congmin, et al.
Publicado: (2020)

Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer
por: Gu, Ming, et al.
Publicado: (2023)

Transcriptome and methylome profiling in a rat model of irritable bowel syndrome induced by stress
por: Zhu, Shengtao, et al.
Publicado: (2018)

An insight into gut microbiota and metabolites in the mice with adenomyosis
por: Chen, Peipei, et al.
Publicado: (2023)

Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome
por: Liu, Yuxia, et al.
Publicado: (2021)

Gut Microbiota Signatures in Gestational Anemia
por: Long, Yan, et al.
Publicado: (2021)

Comparison of the Gut Microbiota Disturbance in Rat Models of Irritable Bowel Syndrome Induced by Maternal Separation and Multiple Early-Life Adversity
por: Enqi, Wu, et al.
Publicado: (2021)

Effects of Metabolites Derived From Gut Microbiota and Hosts on Pathogens
por: Li, Zhendong, et al.
Publicado: (2018)

Alterations in Gut Microbiota Are Correlated With Serum Metabolites in Patients With Insomnia Disorder
por: Zhou, Jing, et al.
Publicado: (2022)

Mucosal-Associated Microbiota Other Than Luminal Microbiota Has a Close Relationship With Diarrhea-Predominant Irritable Bowel Syndrome
por: Yang, Min, et al.
Publicado: (2020)

Anti-osteoporotic drugs affect the pathogenesis of gut microbiota and its metabolites: a clinical study
por: Zhang, Rui-kun, et al.
Publicado: (2023)

Gut microbiota signature as predictors of adverse outcomes after acute ischemic stroke in patients with hyperlipidemia
por: Chen, Jiaxin, et al.
Publicado: (2022)

Gut microbiota in children with split-dose bowel preparations revealed by metagenomics
por: Zou, Yu, et al.
Publicado: (2023)

The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury
por: Li, Yangyang, et al.
Publicado: (2021)

Corrigendum: The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Gut microbiota and fecal metabolic signatures in rat models of disuse-induced osteoporosis
por: Qiao, Xiaochen, et al.
Publicado: (2022)

Gut Microbiota and Fecal Metabolites Associated With Neurocognitive Impairment in HIV-Infected Population
por: Dong, Ruihua, et al.
Publicado: (2021)

Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer
por: Lu, Xingbing, et al.
Publicado: (2023)

Update on gut microbiota in cardiovascular diseases
por: Qian, Buyun, et al.
Publicado: (2022)

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Wu, Jie, et al.
Publicado: (2022)

Causal associations between gut microbiota, gut microbiota-derived metabolites, and cerebrovascular diseases: a multivariable Mendelian randomization study
por: Lin, Dihui, et al.
Publicado: (2023)

Fecal and serum metabolomic signatures and gut microbiota characteristics of allergic rhinitis mice model
por: Chen, Zhen, et al.
Publicado: (2023)

FuZhengHuaYuJiangZhuTongLuoFang Prescription Modulates Gut Microbiota and Gut-Derived Metabolites in UUO Rats
por: Chen, Ziwei, et al.
Publicado: (2022)

Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces
por: Zhong, Xiaohui, et al.
Publicado: (2023)

Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
por: Zhang, Tao, et al.
Publicado: (2022)

The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment
por: Tong, Shuting, et al.
Publicado: (2022)

Differences in the Gut Microbiota Composition and Metabolites Associated With Feeding Intolerance in VLBW Infants With a Gestational Age of ≤ 30 Weeks: A Pilot Study
por: Liu, Xiao-Chen, et al.
Publicado: (2022)

Gut Microbiota and Serum Metabolic Signatures of High-Fat-Induced Bone Loss in Mice
por: Lu, Lingyun, et al.
Publicado: (2021)

Correlation Analysis of Gut Microbiota and Serum Metabolome With Porphyromonas gingivalis-Induced Metabolic Disorders
por: Dong, ZhengJie, et al.
Publicado: (2022)

Vitamin D3 Inhibits Helicobacter pylori Infection by Activating the VitD3/VDR-CAMP Pathway in Mice
por: Zhou, Anni, et al.
Publicado: (2020)

Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites
por: Du, Xu-Qin, et al.
Publicado: (2022)

Gut Microbiota in NSAID Enteropathy: New Insights From Inside
por: Wang, Xianglu, et al.
Publicado: (2021)

Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation
por: Fan, Yadong, et al.
Publicado: (2022)

Comparison of gut microbiota in male MAFLD patients with varying liver stiffness
por: Zhang, Yuheng, et al.
Publicado: (2022)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bvb9tg7lpil97gv7jtrue103no